|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/7125 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 1877070 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06755024.4 |
| Date of filing the European patent application | 2006-05-04 | |
| (97) | Date of publication of the European application | 2008-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2008-12-31 |
| (46) | Date of publication of the claims translation | 2009-05-25 |
| (86) | Number | PCT/EP2006/062067 |
| Date | 2006-05-04 |
| (87) | Number | WO 2006/117400 |
| Date | 2006-11-09 |
| (30) | Number | Date | Country code |
| 05009802 | 2005-05-05 | EP | |
| 680493 P | 2005-05-13 | US |
| (72) |
SCHLINGENSIEPEN, Karl-Hermann, DE
SCHLINGENSIEPEN, Reimar, DE
|
| (73) |
Antisense Pharma GmbH,
Josef Engert Strasse 9, 93053 Regensburg,
DE
|
| (74) |
Leonas Antanas KUČINSKAS,
Dr. Leono A. Kučinsko patentinių paslaugų firma, Kaštonų g. 5-7, LT-01107 Vilnius,
LT
|
| (54) | Beta2 priešprasmių oligonukleotidų terapinis panaudojimas |
| THERAPEUTIC USE OF TGF-BETA2 ANTISENSE OLIGONUCLEOTIDES |
| Payment date | Validity (years) | Amount | |
| 2017-04-18 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-05-04 |